16 Min.

October 2022 Medical News Summary JAMA Medical News

    • Medizin

Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training

Related Content:
Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions Treating Cancer in Pregnant Patients After Roe v Wade Overturned Dobbs Decision Threatens Full Breadth of Ob-Gyn Training

Deciding Whether to Continue Using Teratogenic Drugs in States That Have Banned Abortions; Treating Cancer in Pregnant Patients After Roe v Wade Overturned; Dobbs Decision Threatens Full Breadth of Ob-Gyn Training

Related Content:
Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions Treating Cancer in Pregnant Patients After Roe v Wade Overturned Dobbs Decision Threatens Full Breadth of Ob-Gyn Training

16 Min.

Mehr von JAMA Network

JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Network
JAMA Dermatology Author Interviews
JAMA Network
JAMA Pediatrics Editors' Summary
JAMA Network
JAMA Cardiology Author Interviews
JAMA Network